Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2009
08/13/2009US20090203616 Methods for treating pain and screening analgesic compounds
08/13/2009US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis
08/13/2009US20090203588 Outcome prediction and risk classification in childhood leukemia
08/13/2009US20090203587 Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis
08/13/2009US20090203574 Method for Modulating Hair Growth
08/13/2009US20090203572 Method for in Vitro Molecular Evolution of Protein Function
08/13/2009US20090203548 Complex able to detect an analyte, method for its preparation and uses thereof
08/13/2009US20090203547 Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions
08/13/2009US20090203543 Method for Assaying Enzyme Activity in Histological Sample
08/13/2009US20090203542 Selection system
08/13/2009US20090203541 Msp and its domains as frameworks for novel binding molecules
08/13/2009US20090203540 Methods and Systems for Quality Control Metrics in Hybridization Assays
08/13/2009US20090203539 Avian Sex Identification Oligonucleotides
08/13/2009US20090203536 Assay supports comprising a peg support, said support attached from a peg solution in cloud point (theta solvent) conditions
08/13/2009US20090203533 Methods and Kits for Predicting and Monitoring Direct Response to Cancer Therapy
08/13/2009US20090203143 Trans-splicing mediated photodynamic therapy
08/13/2009US20090203124 Mage-a3 peptides presented by hla-dr1 molecules
08/13/2009US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
08/13/2009US20090203072 Detection for HPV-Induced invasive cancers and their precursor lesions with invasive potential
08/13/2009US20090203065 Cell culture article and screening
08/13/2009US20090203064 Method and device for monitoring platelet function
08/13/2009US20090203063 Droplet-based cell culture and cell assays using digital microfluidics
08/13/2009US20090203062 Method For Identifying And/Or Quantifying Anti-Infective Compounds
08/13/2009US20090203061 Device and method for observing the organization of studied cells cultured in the presence of a concentration gradient of chemotactic molecules
08/13/2009US20090203060 Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
08/13/2009US20090203059 Protease detection product
08/13/2009US20090203058 Method for determination of allergen in environment and kit for simple quantification of allergen
08/13/2009US20090203057 Protein demethylases comprising a jmjc domain
08/13/2009US20090203056 Kit for diagnosis of cancer
08/13/2009US20090203055 Compositions and methods for RNA interference with sialidase expression and uses thereof
08/13/2009US20090203054 HDL Cholesterol Sensor Using Selective Surfactant
08/13/2009US20090203051 Targets in breast cancer for prognosis or therapy
08/13/2009US20090203050 Molecular signaling pathways triggered by rituximab: prognostic, diagnostic, and therapeutic uses
08/13/2009US20090203048 Screening Assays for Antioxidants and Antiproliferative Compounds
08/13/2009US20090203047 88kDa tumorigenic growth factor and antagonists
08/13/2009US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/13/2009US20090203042 Novel bt toxin receptors from lepidopteran insects and methods of use
08/13/2009US20090203041 Bmp4 inhibitors
08/13/2009US20090203035 Fluorescent proteins with increased photostability
08/13/2009US20090203034 Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways
08/13/2009US20090203033 Test and model for alzheimer's disease
08/13/2009US20090203032 Targeted sequencing of genetic regions that differ between two DNA preparations; used to study genetic variation among closely related species and microbial communities; for identifying sources of fecal pollution
08/13/2009US20090203031 Methods for Detecting and Quantifying Specific Microorganisms
08/13/2009US20090203030 Methods for Detecting and Quantifying Specific Probiotic Microorganisms in Animal Feed
08/13/2009US20090203029 Nucleic Acid Analysis Using Non-templated Nucleotide Addition
08/13/2009US20090203028 Novel aptamers that bind to listeria surface proteins
08/13/2009US20090203027 Assays for Detecting T2R76 Taste Modulatory Compounds
08/13/2009US20090203026 Methods and compositions for targeting secretory lysosomes
08/13/2009US20090203025 Branched and multi-chain nucleic acid switches for sensing and screening
08/13/2009US20090203024 Secreted protein called 36p6d5 characteristic of tumors
08/13/2009US20090203023 Concentrating Microorganisms in Aqueous Solution Prior to Selective Staining and Detection
08/13/2009US20090203022 Analysis
08/13/2009US20090203021 Detection of Clostridium difficile
08/13/2009US20090203020 Bovine polymorphisms and methods of predicting bovine traits
08/13/2009US20090203019 Methods of Monitoring Metabolic Pathways
08/13/2009US20090203018 Nucleic acid detection assays employing blocker oligonucleotides
08/13/2009US20090203017 Use of Nucleic Acid Probes to Detect Nucleotide Sequences of Interest in a Sample
08/13/2009US20090203016 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
08/13/2009US20090203015 Multiplex assays for hormonal and growth factor receptors, and uses thereof
08/13/2009US20090203014 Method for diagnosing autism spectrum disorder
08/13/2009US20090203013 Detection of Methicillin-Resistant Staphylococcus aureus
08/13/2009US20090203012 Metabolic Syndrome Genetics
08/13/2009US20090203011 Methods and nucleic acids for analyses of cell proliferative disorders
08/13/2009US20090203010 MSMB-gene based diagnosis, staging and prognosis of prostate cancer
08/13/2009US20090203009 Novel method for high-throughput integrated chemical and biochemical reactions
08/13/2009US20090203008 Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples
08/13/2009US20090203007 Method for obtaining and initiating amplification of a target nucleic acid sequence
08/13/2009US20090203006 Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement
08/13/2009US20090203005 Novel method of designing dna probe chip for room temperature hybridization and the dna probe chip
08/13/2009US20090203004 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy
08/13/2009US20090203003 Inhibition of metallo-beta-lactamase
08/13/2009US20090203002 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
08/13/2009US20090203001 Compositions and methods for diagnosing and treating macular degeneration
08/13/2009US20090203000 Detection of nucleic acids using a cantilever sensor
08/13/2009US20090202999 method for dna breakpoint analysis
08/13/2009US20090202998 Method for the extraction of biomolecules from fixed tissues
08/13/2009US20090202997 Cell-Free In Vitro Transcription and Translation of Membrane Proteins into Tethered Planar Lipid Layers
08/13/2009US20090202996 Genetic polymorphisms for identifying individuals at risk for drug-induced vestibular dysfunction
08/13/2009US20090202995 Molecular cardiotoxicology modeling
08/13/2009US20090202994 Human single nucleotide polymorphisms in ion channels and other proteins
08/13/2009US20090202993 Use of DNA polymerases
08/13/2009US20090202992 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses
08/13/2009US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer
08/13/2009US20090202990 Methods for the selection of aptamers
08/13/2009US20090202989 Egfr and kras mutations
08/13/2009US20090202988 Trap vectors and gene trapping using the same
08/13/2009US20090202987 Canis sphingosine 1-phosphate receptor isoform 2
08/13/2009US20090202986 Methods of optimizing antibody variable region binding affinity
08/13/2009US20090202985 Method and apparatus for detecting an electric field fluctuation associated with the permeabilization of a bacterial cell wall
08/13/2009US20090202984 Single molecule nucleic acid sequence analysis processes and compositions
08/13/2009US20090202983 Method For Determining The Concentration of Virus Particles/Virus Antigens
08/13/2009US20090202659 Modulation of Peripheral Clocks in Adipose Tissue
08/13/2009US20090202638 Bmp gene and fusion protein
08/13/2009US20090202624 Method for detecting carcinoma and agent for suppressing carcinoma
08/13/2009US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
08/13/2009US20090202594 Anti-bacterial Vaccine Compositions
08/13/2009US20090202585 Tat-based tolerogen compositions and methods for making and using same
08/13/2009US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use
08/13/2009US20090202575 Immunostimulatory nucleic acid molecules
08/13/2009US20090202565 Torc polynucleotides and polypeptides and method of use